China Contract Research Organization (CRO) Industry Report, 2013-2016
  • May 2014
  • Hard Copy
  • USD $2,000
  • Pages:85
  • Single User License
    (PDF Unprintable)       
  • USD $1,900
  • Code: ZLC003
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,950
  • Hard Copy + Single User License
  • USD $2,200
      

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share.

As China is full of talents, has advantage of relatively low costs and is rich in disease spectrum, the world’s renowned CRO companies, including Quintiles, Covance, Parexel and Charles River, have entered the Chinese market through sole proprietorship, corporation or acquisition, driving the industry towards standardization to some extent.

At present, there are about 500 companies involved in CRO market in China, but only a few of them are operating at scale and in good shape. WuXi AppTec, ShangPharma Corp, Asymchem and Hangzhou Tigermed Consulting Co., Ltd. Are the leading local CRO companies in China, together holding around 15% of China CRO market.

WuXi AppTec is the largest local CRO player in China, making up about 10% of China CRO market; Hangzhou Tigermed Consulting Co., Ltd. is the only local CRO company listed in China, whose revenue has increased at a rate of above 30% annually over the last three years; Asymchem Inc. takes medical CMO as primary business, with its revenue arriving at RMB 542.8 million in 2013, and has embarked on IPO.

In order to share resources and improve overall competitiveness, some Chinese CRO companies are realizing mutual development by creating alliances, such as Alliance of Biotechnology Outsourcing (or ABO, including 38 companies such as Sino Biological Inc. and Pharmaron). In 2013, the revenue of ABO topped RMB 2 billion, up 11% from a year ago, of which RMB 1 billion came from international services.

?CRO 英文_副本.jpg

China Contract Research Organization (CRO) Industry Report 2013-2016 highlights the following:
20120114.gifStatus quo, market size, competitive landscape, market characteristics and trend of China CRO industry;
20120114.gifInternational environment, industry environment and policy environment of China CRO industry;
20120114.gifOperation, development in China and outlook of 5 global and 9 Chinese CRO companies.

1. Overview of Pharmaceutical Outsourcing
1.1 Definition
1.2 Classification
1.3 CRO

2. Overview of China CRO Market
2.1 Status Quo
2.2 Market Size
2.3 Competitive Landscape
2.4 Market Characteristics
2.5 Trends
2.5.1 Improvement of Industrial Chain
2.5.2 Internationalization of Qualification Certification Standard
2.5.3 Development Driven by Technical Innovation

3. Development Environment of China CRO Industry
3.1 International Environment
3.1.1 Development History
3.1.2 Development Status Quo
3.1.3 Industry Status Quo
3.2 Industry Environment
3.3 Regional Market
3.3.1 Beijing
3.3.2 Shanghai
3.3.3 Chengdu
3.4 Policy Environment

4. Key Foreign CRO Companies
4.1 Covance
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 Development in China
4.2 Parexel
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Development in China
4.3 PPD
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Development in China
4.4 Quintiles
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 Development in China
4.5 Charles River
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Development in China

5. Key Chinese CRO Players
5.1 Wuxi AppTec
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Investment
5.1.6 Forecast and Outlook
5.2 Hangzhou Tigermed Consulting Co., Ltd
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D and Investment
5.2.6 Forecast and Outlook
5.3 ShangPharma Corp
5.3.1 Profile
5.3.2 Operation
5.3.3 Gross Margin
5.4 Venturepharm Laboratories Limited
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.5 Asymchem
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 R&D and Investment
5.5.6 Forecast and Outlook
5.6 Other Companies
5.6.1 Shanghai Mediclon Inc.
5.6.2 Sundia MediTech Company Ltd.
5.6.3 Guangzhou Yushi Medicinal Technology Co., Ltd.
5.6.4 Guangzhou Boji Medical Biotechnological Co., Ltd. 

6. Conclusion and Forecast
6.1 Size of China CRO Market
6.2 Operation Comparison of CRO Companies in China
6.2.1 Revenue
6.2.2 Net Income
6.2.3 Gross Margin
Classification of Pharmaceutical Outsourcing
R&D Process of New Drug
Market Size of China CRO Industry, 2007-2013
Market Share of Major Chinese CRO Companies, 2013
Sales and Profit of Global Top 10 Pharmaceutical Companies, 2013
Size and Growth Rate of Global CRO Market, 2006-2013
Distribution of Major Foreign CRO Companies in China
Number and Growth Rate of Companies in China Pharmaceutical Manufacturing Industry, 2000-2013
Revenue and Growth Rate of China Pharmaceutical Manufacturing Industry, 2000-2013
Total Profit and Growth Rate of China Pharmaceutical Manufacturing Industry, 2000-2013
Amount of Investment Attraction by Beijing Biomedical Industry, 2008-2013
Sales Revenue and YoY Growth Rate of ABO, 2010-2013
Revenue from International Orders and YoY Growth Rate of ABO, 2010-2013
Initiators of Zhongguancun CRO Alliance (Listed Alphabetically)
Platform Advantages of Zhangjiang Drug Valley
List of Major CRO Companies in Zhangjiang Drug Valley
Policies Concerning China CRO Industry
Net Revenue and Net Income of Covance, 2009-2013
Net Revenue of Covance by Business, 2009-2013
Net Revenue Structure of Covance by Business, 2009-2013
Gross Margin of Covance, 2009-2013
Revenue from Services and Net Income of Parexel, 2009-2013
Revenue from Services of Parexel by Product, 2009-2013
Revenue from Services of Parexel by Region, 2009-2013
Structure of Revenue from Services of Parexel by Product, 2009-2013
Structure of Revenue from Services of Parexel by Region, 2009-2013
Net Revenue and Net Income of PPD, 2008-2011
Net Revenue of PPD by Source, 2008-2011
Net Revenue Structure of PPD by Source, 2008-2011
Total Revenue and Net Income of Quintiles, 2010-2013
Revenue of Quintiles by Product, 2009-2013
Total Revenue Structure of Quintiles by Product, 2009-2013
Revenue Structure of Quintiles by Region, 2010-2013
Gross Margin of Quintiles, 2010-2013
Net Sales and Net Income of Charles River, 2009-2013
Net Sales Structure of Charles River by Product, 2011-2013
Net Sales Structure of Charles River by Region, 2010-2013
Gross Margin of Charles River, 2009-2013
Business Areas Distribution of WuXi AppTec
Net Revenue and Net Income of WuXi AppTec, 2009-2013
Revenue Structure of WuXi AppTec by Product, 2009-2013
Revenue Structure of WuXi AppTec by Division, 2012-2013
Revenue Structure of WuXi AppTec by Areas Where Customers Are Located, 2009-2013
Gross Margin of WuXi AppTec, 2009-2013
Gross Margin of WuXi AppTec by Product, 2009-2012
Net Revenue and Net Income of WuXi AppTec, 2012-2016E
Revenue and Net Income of Tigermed, 2009-2013
Revenue Structure of Tigermed by Product, 2009-2013
Revenue Structure of Tigermed by Region, 2009-2013
Gross Margin of Tigermed, 2009-2013
Gross Margin of Tigermed by Product, 2009-2013
Gross Margin of Tigermed by Region, 2009-2013
R&D Costs and % of Total Revenue of Tigermed, 2011-2013
Revenue and Net Income of Tigermed, 2012-2016E
Organizational Structure of ShangPharma
Revenue and Net Income of ShangPharma, 2009-2012
Gross Margin of ShangPharma, 2009-2012
Holding and Affiliate Companies of Venturepharm Laboratories
Revenue and Net Income of Venturepharm Laboratories, 2009-2013
Revenue Structure of Venturepharm Laboratories by Product, 2009-2013
Gross Margin of Venturepharm Laboratories, 2009-2013
Revenue and Net Income of Asymchem, 2011-2013
Revenue Structure of Asymchem by Item, 2011-2013
Gross Margin of Asymchem, 2011-2013
R&D Costs and % of Total Revenue of Asymchem, 2011-2013
Asymchem’s Major Subsidiaries
Orders Won by Asymchem by Type, 2011-2013
Proposed Projects with Funds Raised From Upcoming IPO in May 2014
Revenue and Net Income of Asymchem, 2011-2016E
Market Size of China CRO Industry, 2007-2016E
Revenue of Major Companies in China CRO Industry, 2009-2013
Revenue Growth Rate of Major Companies in China CRO Industry, 2010-2013
Net Income of Major Companies in China CRO Industry, 2009-2013
Net Profit Margin of Major Companies in China CRO Industry, 2009-2013
Gross Margin of Major Companies in China CRO Industry, 2009-2013

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

Global and China Industrial Enzyme Industry Report, 2014-2017

In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzym...

China Blood Product Industry Report, 2015-2018

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Human Vaccine Industry Report, 2015-2018

A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to ...

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号